换一批
换一批A dexamethasone, vinblastine, cyclophosphamide, etoposide, methotrexate and bleomycin (D-VICEMB) protocol as first-line treatment of patients aged 70 years or older affected by intermediate/high grade non-Hodgkin's lymphoma.
作者：
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);博来霉素(Bleomycin);环磷酰胺(Cyclophosphamide);地塞米松(Dexamethasone);无病生存(Disease-Free Survival);依托泊甙(Etoposide);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);淋巴瘤, 非霍奇金(Lymphoma, Non-Hodgkin);男(雄)性(Male);甲氨蝶呤(Methotrexate);存活率(Survival Rate);长春碱(Vinblastine)
PMID
12414356
发布时间
2013-11-21
- 浏览20
Haematologica
1227-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
